What is Lexicon Pharmaceuticals, Inc.'s Market Cap?

Lexicon Pharmaceuticals, Inc.'s Market Cap is $987.8M, based on as-reported figures from SEC (XBRL) filings.

What is Lexicon Pharmaceuticals, Inc.'s Enterprise Value?

Lexicon Pharmaceuticals, Inc.'s Enterprise Value is $848.6M, based on as-reported figures from SEC (XBRL) filings.

What is Lexicon Pharmaceuticals, Inc.'s Price / Sales?

Lexicon Pharmaceuticals, Inc.'s Price / Sales is 23.8×, based on as-reported figures from SEC (XBRL) filings.

What is Lexicon Pharmaceuticals, Inc.'s EV / Revenue?

Lexicon Pharmaceuticals, Inc.'s EV / Revenue is 20.5×, based on as-reported figures from SEC (XBRL) filings.

What is Lexicon Pharmaceuticals, Inc.'s EV / EBITDA?

Lexicon Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Lexicon Pharmaceuticals, Inc.'s Revenue (TTM)?

Lexicon Pharmaceuticals, Inc.'s Revenue (TTM) is $41.5M, based on as-reported figures from SEC (XBRL) filings.

What is Lexicon Pharmaceuticals, Inc.'s Net Income (TTM)?

Lexicon Pharmaceuticals, Inc.'s Net Income (TTM) is -$61.1M, based on as-reported figures from SEC (XBRL) filings.

What is Lexicon Pharmaceuticals, Inc.'s EBITDA?

Lexicon Pharmaceuticals, Inc.'s EBITDA is -$54.0M, based on as-reported figures from SEC (XBRL) filings.

What is Lexicon Pharmaceuticals, Inc.'s Diluted EPS (TTM)?

Lexicon Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -0.14, based on as-reported figures from SEC (XBRL) filings.

What is Lexicon Pharmaceuticals, Inc.'s EBITDA Margin?

Lexicon Pharmaceuticals, Inc.'s EBITDA Margin is -130.3%, based on as-reported figures from SEC (XBRL) filings.

Lexicon Pharmaceuticals, Inc. (LXRX) Financial Statements

Lexicon Pharmaceuticals, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SDWCZ8

XNAS · usd

2.22▼ 0.02 (-0.89%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close2.24

Day's Range2.19 – 2.25

52-Week Range1.05 – 2.68

Volume1.6M

Avg Volume2.7M

Share Statistics

Shares Outstanding

Employees81

ExchangeXNAS

Listed2000-04-07

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Lexicon Pharmaceuticals, Inc. (LXRX)

What is Lexicon Pharmaceuticals, Inc.'s Market Cap?: Lexicon Pharmaceuticals, Inc.'s Market Cap is $987.8M, based on as-reported figures from SEC (XBRL) filings.
What is Lexicon Pharmaceuticals, Inc.'s Enterprise Value?: Lexicon Pharmaceuticals, Inc.'s Enterprise Value is $848.6M, based on as-reported figures from SEC (XBRL) filings.
What is Lexicon Pharmaceuticals, Inc.'s Price / Sales?: Lexicon Pharmaceuticals, Inc.'s Price / Sales is 23.8×, based on as-reported figures from SEC (XBRL) filings.
What is Lexicon Pharmaceuticals, Inc.'s EV / Revenue?: Lexicon Pharmaceuticals, Inc.'s EV / Revenue is 20.5×, based on as-reported figures from SEC (XBRL) filings.
What is Lexicon Pharmaceuticals, Inc.'s EV / EBITDA?: Lexicon Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Lexicon Pharmaceuticals, Inc.'s Revenue (TTM)?: Lexicon Pharmaceuticals, Inc.'s Revenue (TTM) is $41.5M, based on as-reported figures from SEC (XBRL) filings.
What is Lexicon Pharmaceuticals, Inc.'s Net Income (TTM)?: Lexicon Pharmaceuticals, Inc.'s Net Income (TTM) is -$61.1M, based on as-reported figures from SEC (XBRL) filings.
What is Lexicon Pharmaceuticals, Inc.'s EBITDA?: Lexicon Pharmaceuticals, Inc.'s EBITDA is -$54.0M, based on as-reported figures from SEC (XBRL) filings.
What is Lexicon Pharmaceuticals, Inc.'s Diluted EPS (TTM)?: Lexicon Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -0.14, based on as-reported figures from SEC (XBRL) filings.
What is Lexicon Pharmaceuticals, Inc.'s EBITDA Margin?: Lexicon Pharmaceuticals, Inc.'s EBITDA Margin is -130.3%, based on as-reported figures from SEC (XBRL) filings.